User menu

Intranasal immunization against influenza virus using polymeric particles.

Bibliographic reference Lemoine, D. ; Deschuyteneer, M ; Hogge, F ; Préat, Véronique. Intranasal immunization against influenza virus using polymeric particles.. In: Journal of biomaterials science. Polymer edition, Vol. 10, no. 8, p. 805-25 (1999)
Permanent URL http://hdl.handle.net/2078.1/8352
  1. O'Hagan D.T., McGee J.P., Holmgren J., Mowat A.MCl., Donachie A.M., Mills K.H.G., Gaisford W., Rahman D., Challacombe S.J., Biodegradable microparticles for oral immunization, 10.1016/0264-410x(93)90011-l
  2. Haas Susan, Miura-Fraboni Judy, Zavala Fidel, Murata Kenichiro, Leone-Bay Andrea, Santiago Noemi, Oral immunization with a model protein entrapped in microspheres prepared from derivatized α-amino acids, 10.1016/s0264-410x(97)81489-2
  3. Eldridge John H., Hammond Charlotte J., Meulbroek Jonathan A., Staas Jay K., Gilley Richard M., Tice Thomas R., Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patches, 10.1016/0168-3659(90)90133-e
  4. Jani P., Halbert G. W., Langridge J., Florence A. T., The Uptake and Translocation of Latex Nanospheres and Microspheres after Oral Administration to Rats, 10.1111/j.2042-7158.1989.tb06377.x
  5. Mauduit J., S. T. P. Pharma Sciences, 3, 197 (1993)
  6. Lemoine D., Francois C., Kedzierewicz F., Preat V., Hoffman M., Maincent P., Stability study of nanoparticles of poly(ɛ-caprolactone), poly(d,l-lactide) and poly(d,l-lactide-co-glycolide), 10.1016/0142-9612(96)00049-x
  7. ALMEIDA A. J., ALPAR H. O., BROWN M. R. W., Immune Response to Nasal Delivery of Antigenically Intact Tetanus Toxoid Associated with Poly(l-lactic acid) Microspheres in Rats, Rabbits and Guinea-pigs, 10.1111/j.2042-7158.1993.tb05532.x
  8. Shahin R., Infec. Immun., 63, 1195 (1995)
  9. Changhong Y, Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres, 10.1016/0264-410x(96)00063-1
  10. Eyles Jim E., Sharp Gregory J.E., Diane Williamson E., Spiers Ian D., Oya Alpar H., Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse, 10.1016/s0264-410x(97)00249-1
  11. HERITAGE, BROOK, UNDERDOWN, McDERMOTT, Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes : NALT activation following intranasal microparticle administration, 10.1046/j.1365-2567.1998.00420.x
  12. Higaki Megumu, Takase Tsugiko, Igarashi Rie, Suzuki Yujiro, Aizawa Chikara, Mizushima Yutaka, Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin, 10.1016/s0264-410x(97)00248-x
  13. UGOZZOLI, O’HAGAN, OTT, Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses : Intranasal HSV vaccines, 10.1046/j.1365-2567.1998.00441.x
  14. Ray R., Novak M., Duncan J. D., Matsuoka Y., Compans R. W., Microencapsulated Human Parainfluenza Virus Induces a Protective Immune Response, 10.1093/infdis/167.3.752
  15. Cahill E, Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles, 10.1016/0264-410x(94)00008-b
  16. Alpar H. O., Proc. Int. Symp. Contr. Rel. Bioact. Mater., 21, 867 (1994)
  17. Moore A, Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells, 10.1016/0264-410x(95)00184-3
  18. Wee S. F., Proc. Int. Symp. Contr. Rel. Bioact. Mater, 22, 566 (1995)
  19. Carr Richard M., Lolachi Christopher M., Albaran Renato G., Ridley Deanne M., Montgomery Paul C., O'sullivan Nancy L., Nasal-Associated Lymphoid Tissue is an Inductive Site for Rat Tear IgA Antibody Responses, 10.3109/08820139609055728
  20. Fields B. N., Virology (1996)
  21. McGhee Jerry R., Mestecky Jiri, Dertzbaugh Mark T., Eldridge John H., Hirasawa Masatomo, Kiyono Hiroshi, The mucosal immune system: from fundamental concepts to vaccine development, 10.1016/0264-410x(92)90021-b
  22. Spit B. J., Cell Tissue Res., 255, 193 (1989)
  23. Frieke Kuper C., Koornstra Petra J., Hameleers Dona M.H., Biewenga Jeike, Spit Ben J., Duijvestijn Adrian M., van Breda Vriesman Peter J.C., Sminia Taede, The role of nasopharyngeal lymphoid tissue, 10.1016/0167-5699(92)90158-4
  24. Lemoine D., S. T. P. Pharma Sciences, Thematic issue on mucosal immunity, 8, 5 (1998)
  25. Waldman R.H., Stone J., Bergmann Κ.-Ch., Khakoo R., Lazzell V., Jacknowitz A., Waldman E.R., Howard S., Secretory Antibody Following Oral Influenza Immunization, 10.1097/00000441-198612000-00006
  26. Moldoveanu Z., Clements M.L., Prince S.J., Murphy B.R., Mestecky J., Human immune responses to influenza virus vaccines administered by systemic or mucosal routes, 10.1016/0264-410x(95)00016-t
  27. Ahmeida E.T.S.Ben, Gregoriadis G., Potter C.W., Jennings R., Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice, 10.1016/0264-410x(93)90099-j
  28. El Guink Nadia, Kris Richard M., Goodman-Snitkoff Gail, Small Parker A., Mannino Raphael J., Intranasal immunization with proteoliposomes protects against influenza, 10.1016/0264-410x(89)90055-8
  29. de Haan A., Geerligs H.J., Huchshorn J.P., van Scharrenburg G.J.M., Palache A.M., Wilschut J., Mucosal immunoadjuvant activity of liposomes: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes, 10.1016/0264-410x(95)93129-w
  30. Gizurarson S., Vaccine Res., 5, 69 (1996)
  31. Rietschel E., Pour la science, 180, 48 (1992)
  32. Lemoine D, Préat V, Polymeric nanoparticles as delivery system for influenza virus glycoproteins, 10.1016/s0168-3659(97)00241-1
  33. Jeffery Hayley, Davis Stanley S., O'Hagan Derek T., 10.1023/a:1018980020506
  34. Robards A. W., Procedures in Electron Microscopy (1993)
  35. Echlin Patrick, Low-Temperature Microscopy and Analysis, ISBN:9781489923042, 10.1007/978-1-4899-2302-8
  36. Towbin H., Staehelin T., Gordon J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications., 10.1073/pnas.76.9.4350
  37. Hawkes Richard, Niday Evelyn, Gordon Julian, A dot-immunobinding assay for monoclonal and other antibodies, 10.1016/0003-2697(82)90677-7
  38. Laver W.G., Kilbourne Edwin D., Identification in a recombinant influenza virus of structural proteins derived from both parents, 10.1016/0042-6822(66)90125-5
  39. Voller, A., Bidwell, D. and Bartlett, A. 1980.Manual of Clinical Immunology, Edited by: Rose, N. R. and Friedman, H. 359Washington, DC: American Society of Microbiology.
  40. Bancroft J. D., Theory and Practice of Histological Techniques (1996)
  41. Renfrey S., Watts A., Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom, 10.1016/0264-410x(94)90227-5
  42. Kreuter Jöurg, Speiser Peter P., In Vitro Studies of Poly(methyl Methacrylate) Adjuvants, 10.1002/jps.2600651115
  43. Mestecky J., Moldoveanu Z., Novak M., Huang W.-Q., Gilley R.M., Staas J.K., Schafer D., Compans R.W., Biodegradable microspheres for the delivery of oral vaccines, 10.1016/0168-3659(94)90160-0
  44. Santiago Noemi, Milstein Sam, Rivera Theresa, Garcia Elisa, Zaidi Tabassum, Hong Hyunki, Bucher Doris, 10.1023/a:1018992924025
  45. Wharton, S. A., Weis, W., Skehel, J. J. and D. C. 1989.The Influenza Viruses, Edited by: Krug, R. M. 153New York: Plenum Press.
  46. O'Hagan D.T., Rafferty D., Wharton S., Illum L., Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system, 10.1016/0264-410x(93)90313-m
  47. Kreuter J., Liehl E., Berg U., Soliva M., Speiser P.P., Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants, 10.1016/0264-410x(88)90220-4
  48. Kreuter J., Infect. Immunol., 19, 667 (1978)